check_circleStudy Completed

Bacterial Infections

Ciprofloxacin oral suspension administered for 3 days versus ciprofloxacin oral suspension administered for 5 days in children and juveniles for the treatment of Shigella dysenteriae type one dysentery

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
253
Trial Dates
May 1996 - June 2000
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

A prospective, controlled, randomized, double-blind, multicentre study comparing the efficacy and safety of ciprofloxacin oral suspension administered for 3 days (short course) versus ciprofloxacin oral suspension administered for 5 days (standard course) in children and juveniles for the treatment of Shigella dysenteriae type one dysentery (BAY q 3939/582002)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A